TrialJAMA oncology2016
Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial.
Saby George et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
92 papers cite itlatest 60 shown
this paperpooled ittrialcites it